Series Introduction | |
Preface | |
Contributors | |
Coronary Thrombolysis: Background and Factors Underlying Its Emergence | p. 1 |
Thrombolytic Agents | p. 11 |
The Nature of Atherosclerotic Lesions Giving Rise to Acute Coronary Thrombosis | p. 35 |
The Objectives of Coronary Thrombolysis | p. 53 |
The Impact of Time to Treatment on the Efficacy of Coronary Thrombolysis | p. 65 |
Procoagulant Effects of Fibrinolytic Agents | p. 77 |
The Role of Platelets in Thrombolysis, Thrombosis, and Thrombolytic Therapy | p. 101 |
Relationships Between Suppression of Coagulation and Prevention of Reocclusion | p. 123 |
Strengths and Limitations of Specific Antithrombotic Regimens and Agents | p. 143 |
Discrepancies Between End-Point Results in Clinical Trials of Thrombolytic Therapy: The Salvage Paradigm Revisited | p. 167 |
Coronary Artery Patency | p. 183 |
Mortality as an End Point in Studies of Coronary Thrombolysis | p. 193 |
Clinical Factors Militating Against Sustained Patency and Their Consequences | p. 221 |
Efficacy of Currently Available Conjunctive Regimens | p. 255 |
Myocardial Reperfusion Injury: Concepts, Mechanisms, and Therapeutic Strategies | p. 271 |
Epilogue. Controversy and Clarification: Preliminary Results of the GUSTO Trial | p. 303 |
Index | p. 317 |
Table of Contents provided by Blackwell. All Rights Reserved. |